A targeted vaccination programme against Meningitis B is set to commence, offering the crucial jab to approximately one million young people across the UK. This initiative comes in response to concerns over infection rates this year, particularly among those in close-contact environments. The two-dose vaccine will be made available free on the NHS to pupils in their final year of secondary school (born between 1st September 2007 and 31st August 2008) and individuals aged 18 to 25 who are embarking on university or residential further education for the first time this autumn.
Meningitis is a serious infection affecting the protective membranes surrounding the brain and spinal cord. Meningitis B is one of several types and can lead to severe health complications. While babies have been routinely vaccinated against MenB since 2015, this new programme addresses a gap for older age groups who did not receive the jab as infants. Appointments for eligible individuals are expected to become available from the end of July, with plans for community pharmacies in England to administer the doses. Those eligible will be contacted directly via the NHS App, text, and email, while new university students can book appointments directly with participating pharmacies.
The decision to offer a targeted rather than universal vaccination campaign for teenagers stems from advice by the Joint Committee on Vaccination and Immunisation (JCVI). The government advisers concluded that a widespread NHS catch-up campaign for all teenagers against MenB was not cost-effective, a stance they have committed to keeping under review. Factors influencing this decision include the vaccine's varying effectiveness in young people compared to infants, its protection against only the most common B strains, and its limited ability to prevent bacterial transmission between individuals. Protection from the vaccine is also not considered lifelong.
Meningitis B spreads through close personal contact, such as the exchange of saliva via coughs, sneezes, kissing, or sharing items like vapes and drinks. Students heading to university are identified as a higher-risk group due to increased close contact with new individuals in shared living spaces, a factor that contributes to the typical peak in invasive meningococcal disease cases during October and November each year. This year has seen notable clusters of cases in areas including Kent, Dorset, and Berkshire.
It is important to note that all teenagers are currently offered the MenACWY vaccine, which protects against other strains of meningitis but not MenB. While older adults can also be affected by meningitis, particularly if they have compromised immune systems, babies and young people remain the most vulnerable groups. Individuals with health concerns or questions about their eligibility should consult their GP or call NHS 111.
Source: NHS